标题
Therapeutic strategies for thrombosis: new targets and approaches
作者
关键词
-
出版物
NATURE REVIEWS DRUG DISCOVERY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-03-04
DOI
10.1038/s41573-020-0061-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty
- (2020) Jeffrey I. Weitz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Functional significance of the platelet immune receptors GPVI and CLEC-2
- (2019) Julie Rayes et al. JOURNAL OF CLINICAL INVESTIGATION
- Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
- (2019) Marie Scully et al. NEW ENGLAND JOURNAL OF MEDICINE
- Retrospective comparison of ultrasound facilitated catheter-directed thrombolysis and systemically administered half-dose thrombolysis in treatment of pulmonary embolism
- (2019) Mohsen Sharifi et al. VASCULAR MEDICINE
- Role of Platelet Transfusion in the Reversal of Anti-Platelet Therapy
- (2019) Srikanth Nagalla et al. TRANSFUSION MEDICINE REVIEWS
- Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
- (2019) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers
- (2019) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- MAA868, a novel FXI antibody with a unique binding mode, shows durable effects on markers of anticoagulation in humans
- (2019) Alexander W. Koch et al. BLOOD
- Intrinsic Pathway of Coagulation and Thrombosis
- (2019) Steven P. Grover et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Contact Activation Inhibitor and Factor XI Antibody, AB023, Produces Safe, Dose-Dependent Anticoagulation in a Phase 1 First-In-Human Trial
- (2019) Christina U. Lorentz et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT017, an Antiplatelet GPVI (Glycoprotein VI) Fab
- (2019) Christine Voors-Pette et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Neutrophils and neutrophil extracellular traps enhance venous thrombosis in mice bearing human pancreatic tumors
- (2019) Yohei Hisada et al. HAEMATOLOGICA
- Neutrophil Extracellular Traps
- (2019) Charlotte Thålin et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Clinical significance of altered collagen-receptor functioning in platelets with emphasis on glycoprotein VI
- (2019) Alan T. Nurden BLOOD REVIEWS
- Revacept, a Novel Inhibitor of Platelet Adhesion, in Patients Undergoing Elective PCI—Design and Rationale of the Randomized ISAR-PLASTER Trial
- (2019) Stefanie Schüpke et al. THROMBOSIS AND HAEMOSTASIS
- Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
- (2019) Renato D. Lopes et al. JAMA Cardiology
- Very Short Dual Antiplatelet Therapy after Drug-eluting Stent Implantation in Patients with High Bleeding Risk: Insight from the STOPDAPT-2 Trial
- (2019) Hirotoshi Watanabe et al. CIRCULATION
- A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI
- (2019) Daniel M.F. Claassens et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease
- (2019) Satoshi Yasuda et al. NEW ENGLAND JOURNAL OF MEDICINE
- From Patients to Platelets and Back Again: Pharmacological Approaches to Glycoprotein VI, a Thrilling Antithrombotic Target with Minor Bleeding Risks
- (2019) Augusto Martins Lima et al. THROMBOSIS AND HAEMOSTASIS
- Transcatheter aortic valve replacement with a focus on transcarotid: a review of the current literature
- (2019) Issa Pour-Ghaz et al. Annals of Translational Medicine
- Genetic association between plasminogen activator inhibitor‐1 rs1799889 polymorphism and venous thromboembolism: Evidence from a comprehensive meta‐analysis
- (2019) Guangbin Huang et al. CLINICAL CARDIOLOGY
- Tissue Factor
- (2018) Steven P. Grover et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The search for new antithrombotic mechanisms and therapies that may spare hemostasis
- (2018) Edward F. Plow et al. BLOOD
- Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome
- (2018) Vittorio Pengo et al. BLOOD
- Mechanisms of platelet clearance and translation to improve platelet storage
- (2018) M. Edward Quach et al. BLOOD
- Activated protein C, protease activated receptor 1, and neuroprotection
- (2018) John H. Griffin et al. BLOOD
- Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque–triggered thrombus formation in humans
- (2018) Kristina Busygina et al. BLOOD
- Andexanet Alfa: First Global Approval
- (2018) Young-A Heo DRUGS
- Platelet collagen receptor Glycoprotein VI-dimer recognizes fibrinogen and fibrin through their D-domains, contributing to platelet adhesion and activation during thrombus formation
- (2018) I. Induruwa et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
- (2018) Stuart J Connolly et al. LANCET
- Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
- (2018) Sonia S Anand et al. LANCET
- Current and future antiplatelet therapies: emphasis on preserving haemostasis
- (2018) James D. McFadyen et al. Nature Reviews Cardiology
- RAP GTPases and platelet integrin signaling
- (2018) Lucia Stefanini et al. PLATELETS
- PAR1 agonists stimulate APC-like endothelial cytoprotection and confer resistance to thromboinflammatory injury
- (2018) Karen De Ceunynck et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
- (2018) William J. Powers et al. STROKE
- Dimeric Glycoprotein VI Binds to Collagen but Not to Fibrin
- (2018) Mariam Ebrahim et al. THROMBOSIS AND HAEMOSTASIS
- Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016
- (2018) Elias J. Dayoub et al. JAMA Internal Medicine
- A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents
- (2018) Stephanie Joppa et al. Journal of Clinical Medicine
- Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
- (2018) Pascal Vranckx et al. LANCET
- Does fibrin(ogen) bind to monomeric or dimeric GPVI, or not at all?
- (2018) Alexandre Slater et al. PLATELETS
- The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis
- (2018) Hanny Al-Samkari et al. Cancers
- Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activ
- (2018) Patrick Lyden et al. ANNALS OF NEUROLOGY
- Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis
- (2018) Jennifer R. Brown et al. BRITISH JOURNAL OF HAEMATOLOGY
- The prothrombotic state in atrial fibrillation: pathophysiological and management implications
- (2018) Ahsan A Khan et al. CARDIOVASCULAR RESEARCH
- Case-based implementation of the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease
- (2017) Jean-Philippe Collet et al. EUROPEAN HEART JOURNAL
- Discovery methods of coagulation-inhibiting drugs
- (2017) Antonio Gómez-Outes et al. Expert Opinion on Drug Discovery
- Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis
- (2017) Carlo Patrono et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation
- (2017) Lucas N. Marzec et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients
- (2017) Thomas A. Mavrakanas et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Negative regulators of platelet activation and adhesion
- (2017) L. Stefanini et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Fibrinolysis: from blood to the brain
- (2017) R. L. Medcalf JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risks
- (2017) Kristell Lebozec et al. mAbs
- Milestone 1: Discovery and purification of heparin
- (2017) Gregory B. Lim Nature Reviews Cardiology
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
- (2017) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
- (2017) Charles V. Pollack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
- (2017) Jeffrey I. Weitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding
- (2017) Pancras C. Wong et al. Science Translational Medicine
- Coagulation factor and protease pathways in thrombosis and cardiovascular disease
- (2017) Hugo ten Cate et al. THROMBOSIS AND HAEMOSTASIS
- New developments in anticoagulants: Past, present and future
- (2017) Job Harenberg et al. THROMBOSIS AND HAEMOSTASIS
- Thrombotic thrombocytopenic purpura
- (2017) Johanna A. Kremer Hovinga et al. Nature Reviews Disease Primers
- 2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis
- (2017) Jeffrey I. Weitz et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation
- (2017) Simon J. Wilson et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Is platelet transfusion efficient to restore platelet reactivity in patients who are responders to aspirin and/or clopidogrel before emergency surgery?
- (2017) Guillaume Taylor et al. Journal of Trauma and Acute Care Surgery
- Tumor-Derived Exosomes Induce the Formation of Neutrophil Extracellular Traps: Implications For The Establishment of Cancer-Associated Thrombosis
- (2017) Ana C. Leal et al. Scientific Reports
- Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory DiseasesHighlights
- (2016) Katrin F. Nickel et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- 2016 Scientific Sessions Sol Sherry Distinguished Lecturer in ThrombosisHighlights
- (2016) John H. Griffin et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Inhibition of Protein Disulfide Isomerase in Thrombosis
- (2016) Roelof H. Bekendam et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Emerging anticoagulant strategies
- (2016) James C. Fredenburgh et al. BLOOD
- Arf6 controls platelet spreading and clot retraction via integrin IIb 3 trafficking
- (2016) Y. Huang et al. BLOOD
- Protease-activated receptors in hemostasis
- (2016) M. T. Nieman BLOOD
- Antithrombotic Therapy for VTE Disease
- (2016) Clive Kearon et al. CHEST
- Global Burden of Thrombosis: Table.
- (2016) Aaron M. Wendelboe et al. CIRCULATION RESEARCH
- Discovery and antiplatelet activity of a selective PI3Kβ inhibitor (MIPS-9922)
- (2016) Zhaohua Zheng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The Intrinsic Pathway of Coagulation as a Target for Antithrombotic Therapy
- (2016) Allison P. Wheeler et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer
- (2016) Thomas J. Povsic et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
- (2016) Glenn N. Levine et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A century of heparin: past, present and future
- (2016) H. C. Hemker JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Structural and functional insights into enzymes of the vitamin K cycle
- (2016) J.-K. Tie et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Pharmacology of anticoagulants used in the treatment of venous thromboembolism
- (2016) Edith A. Nutescu et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial
- (2016) M Irem Baharoglu et al. LANCET
- Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial
- (2016) A Michael Lincoff et al. LANCET
- Platelet Physiology
- (2016) Andrew Frelinger et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- The VWF-GPIb axis in ischaemic stroke: lessons from animal models
- (2016) Frederik Denorme et al. THROMBOSIS AND HAEMOSTASIS
- Tissue factor expressed by adherent cells contributes to hemodialysis-membrane thrombogenicity
- (2016) Souad Lakbakbi et al. THROMBOSIS RESEARCH
- The hemostatic role of factor XI
- (2016) Cristina Puy et al. THROMBOSIS RESEARCH
- A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation
- (2016) Yasin Kokoye et al. THROMBOSIS RESEARCH
- Comparison of bivalirudin to lepirudin and argatroban in patients with heparin-induced thrombocytopenia
- (2015) J. Bain et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease
- (2015) Paul A. Gurbel et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Parmodulins inhibit thrombus formation without inducing endothelial injury caused by vorapaxar
- (2015) O. Aisiku et al. BLOOD
- Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation
- (2015) E. Mammadova-Bach et al. BLOOD
- Fibrin activates GPVI in human and mouse platelets
- (2015) O. M. Alshehri et al. BLOOD
- A novel snake venom-derived GPIb antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury
- (2015) Ting-Ting Li et al. BRITISH JOURNAL OF PHARMACOLOGY
- A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism
- (2015) Gregory Piazza et al. JACC-Cardiovascular Interventions
- Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III
- (2015) Jenny Björkqvist et al. JOURNAL OF CLINICAL INVESTIGATION
- Exploration of efficacy and bleeding with combined phosphoinositide 3-kinase β inhibition and aspirin in man
- (2015) S. Nylander et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Idarucizumab for Dabigatran Reversal
- (2015) Charles V. Pollack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis
- (2015) Harry R. Büller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis
- (2015) Paul E. Marik et al. PLoS One
- Venous thrombosis
- (2015) Alisa S. Wolberg et al. Nature Reviews Disease Primers
- Factor XII Regulates the Pathological Process of Thrombus Formation on Ruptured Plaques
- (2014) Marijke J.E. Kuijpers et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- New Targets for Atherothrombosis
- (2014) Nigel Mackman ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Factor XI Regulates Pathological Thrombus Formation on Acutely Ruptured Atherosclerotic Plaques
- (2014) Maurits L. van Montfoort et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Biology of tissue factor pathway inhibitor
- (2014) J. P. Wood et al. BLOOD
- Nontoxic polyphosphate inhibitors reduce thrombosis while sparing hemostasis
- (2014) R. J. Travers et al. BLOOD
- Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbits
- (2014) Jonathan W. Yau et al. BLOOD
- Platelet 12-LOX is essential for Fc RIIa-mediated platelet activation
- (2014) J. Yeung et al. BLOOD
- Of von Willebrand factor and platelets
- (2014) Marijke Bryckaert et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Shaping the platelet response to vascular injury
- (2014) Timothy J. Stalker et al. CURRENT OPINION IN HEMATOLOGY
- Factor XII: a drug target for safe interference with thrombosis and inflammation
- (2014) Ellinor Kenne et al. DRUG DISCOVERY TODAY
- Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial Hemorrhage
- (2014) Saurav Chatterjee et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk
- (2014) M. Larsson et al. Science Translational Medicine
- Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
- (2014) Walter N. Kernan et al. STROKE
- Cytoprotective-selective activated protein C therapy for ischaemic stroke
- (2014) Berislav Zlokovic et al. THROMBOSIS AND HAEMOSTASIS
- An update on type 2B von Willebrand disease
- (2014) Sameh Mikhail et al. Expert Review of Hematology
- Thrombosis: tangled up in NETs
- (2013) K. Martinod et al. BLOOD
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- A directional switch of integrin signalling and a new anti-thrombotic strategy
- (2013) Bo Shen et al. NATURE
- Scientific considerations in the review and approval of generic enoxaparin in the United States
- (2013) Sau Lee et al. NATURE BIOTECHNOLOGY
- A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa
- (2013) Genmin Lu et al. NATURE MEDICINE
- Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
- (2013) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice
- (2013) K. Martinod et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 12-lipoxygenase activity plays an important role in PAR4 and GPVI-mediated platelet reactivity
- (2013) Jennifer Yeung et al. THROMBOSIS AND HAEMOSTASIS
- Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis
- (2013) Yan Hou et al. THROMBOSIS AND HAEMOSTASIS
- Novel Antiplatelet Agents: ALX-0081, a Nanobody Directed towards von Willebrand Factor
- (2013) Jozef Bartunek et al. Journal of Cardiovascular Translational Research
- Moderate Pulmonary Embolism Treated With Thrombolysis (from the “MOPETT” Trial)
- (2012) Mohsen Sharifi et al. AMERICAN JOURNAL OF CARDIOLOGY
- Antisense inhibition of coagulation factor XI prolongs APTT without increased bleeding risk in cynomolgus monkeys
- (2012) H. S. Younis et al. BLOOD
- Parenteral Anticoagulants
- (2012) David A. Garcia et al. CHEST
- Role of Tissue Factor in Atherothrombosis
- (2012) A. Phillip Owens et al. Current Atherosclerosis Reports
- A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial
- (2012) Thomas J. Povsic et al. EUROPEAN HEART JOURNAL
- Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: Systematic review and meta-analysis
- (2012) Dániel Aradi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents
- (2012) Reema Jasuja et al. JOURNAL OF CLINICAL INVESTIGATION
- Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo
- (2012) Marie-Luise von Brühl et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Investigations of human platelet-type 12-lipoxygenase: role of lipoxygenase products in platelet activation
- (2012) Kenneth N. Ikei et al. JOURNAL OF LIPID RESEARCH
- Human target validation of phosphoinositide 3-kinase (PI3K)β: effects on platelets and insulin sensitivity, using AZD6482 a novel PI3Kβ inhibitor
- (2012) S. NYLANDER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism
- (2012) Timothy A. Brighton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vorapaxar in the Secondary Prevention of Atherothrombotic Events
- (2012) David A. Morrow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aspirin for Preventing the Recurrence of Venous Thromboembolism
- (2012) Cecilia Becattini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nucleic acid scavengers inhibit thrombosis without increasing bleeding
- (2012) S. Jain et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Platelets at work in primary hemostasis
- (2011) Katleen Broos et al. BLOOD REVIEWS
- Novel Antiplatelet Drug Revacept (Dimeric Glycoprotein VI-Fc) Specifically and Efficiently Inhibited Collagen-Induced Platelet Aggregation Without Affecting General Hemostasis in Humans
- (2011) Martin Ungerer et al. CIRCULATION
- Randomized Trial of Atopaxar in the Treatment of Patients With Coronary Artery Disease
- (2011) Stephen D. Wiviott et al. CIRCULATION
- Safety and Tolerability of Atopaxar in the Treatment of Patients With Acute Coronary Syndromes
- (2011) Michelle L. O'Donoghue et al. CIRCULATION
- Single intravenous administration of TB-402 for the prophylaxis of venous thromboembolism after total knee replacement: a dose-escalating, randomized, controlled trial
- (2011) P. VERHAMME et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Neutrophil extracellular traps promote deep vein thrombosis in mice
- (2011) A. BRILL et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A Prospective Natural-History Study of Coronary Atherosclerosis
- (2011) Gregg W. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
- (2011) John H. Alexander et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
- (2011) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
- (2011) Pierluigi Tricoci et al. NEW ENGLAND JOURNAL OF MEDICINE
- The von Willebrand Inhibitor ARC1779 Reduces Cerebral Embolization After Carotid Endarterectomy
- (2011) Hugh S. Markus et al. STROKE
- Vitamin K Antagonists – Current Concepts and Challenges
- (2011) Hayan Moualla et al. THROMBOSIS RESEARCH
- Protamine neutralisation of low molecular weight heparins and their oligosaccharide components
- (2010) Mette Schroeder et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo
- (2010) Q. Cheng et al. BLOOD
- Deletion of the p110 isoform of phosphoinositide 3-kinase in platelets reveals its central role in Akt activation and thrombus formation in vitro and in vivo
- (2010) V. Martin et al. BLOOD
- Tolerability and pharmacokinetics of TB-402 in healthy male volunteers
- (2010) Peter Verhamme et al. CLINICAL THERAPEUTICS
- Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease
- (2010) S. Goto et al. EUROPEAN HEART JOURNAL
- Platelet receptor signaling in thrombus formation
- (2010) David Stegner et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- A 2-Step Mechanism of Arterial Thrombus Formation Induced by Human Atherosclerotic Plaques
- (2010) Armin J. Reininger et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
- (2010) L. A. Honigberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis
- (2009) F. Dentali et al. BLOOD
- A multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome*
- (2009) Jean-Louis Vincent et al. CRITICAL CARE MEDICINE
- Venous and arterial thrombosis: Two aspects of the same disease?
- (2009) Paolo Prandoni European Journal of Internal Medicine
- Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
- (2009) Timothy Watson et al. LANCET
- Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
- (2009) Gilles Montalescot et al. LANCET
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tissue Factor in Brain Is Not Saturated With Factor VIIa
- (2009) Maureane Hoffman et al. STROKE
- Tissue factor activity of blood mononuclear cells is increased after total knee arthroplasty
- (2009) Gerhard J. Johnson et al. THROMBOSIS AND HAEMOSTASIS
- Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo
- (2008) Christian Schulz et al. BASIC RESEARCH IN CARDIOLOGY
- Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory study
- (2008) B. I. ERIKSSON et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromsø study
- (2008) S. K. BRAEKKAN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Complementary roles of platelets and coagulation in thrombus formation on plaques acutely ruptured by targeted ultrasound treatment: a novel intravital model
- (2008) M. J. E. KUIJPERS et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Triggers, targets and treatments for thrombosis
- (2008) Nigel Mackman NATURE
- Glycoprotein Ibα and von Willebrand factor in primary platelet adhesion and thrombus formation: Lessons from mutant mice
- (2008) Wolfgang Bergmeier et al. THROMBOSIS AND HAEMOSTASIS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started